TL;DR: The Centers for Medicare & Medicaid Services modified NCD 71, the National Coverage Determination governing pediatric liver transplantation, effective January 9, 2026. Here's what billing teams need to know.
This update to the CMS pediatric liver transplantation coverage policy clarifies who qualifies for Medicare reimbursement and which hospital programs meet institutional criteria under NCD 71 in the CMS system. The policy does not list specific CPT or HCPCS codes, but the coverage criteria are precise — and the institutional approval requirements create real claim denial risk if your facility's documentation isn't current.
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Pediatric Liver Transplantation |
| Policy Code | NCD 71 |
| Change Type | Modified |
| Effective Date | 2026-01-09 |
| Impact Level | High |
| Specialties Affected | Pediatric surgery, transplant surgery, inpatient hospital billing, pediatric hepatology |
| Key Action | Confirm your facility holds current CMS institutional approval for pediatric liver transplants before billing Medicare for this service |
CMS Pediatric Liver Transplantation Coverage Criteria and Medical Necessity Requirements 2026
The CMS pediatric liver transplantation coverage policy covers liver transplantation for patients under age 18. Two primary diagnoses anchor the medical necessity criteria: extrahepatic biliary atresia and end-stage liver disease of any other form.
That's actually a broad medical necessity standard — "any other form" of end-stage liver disease gives treating physicians meaningful latitude. The limiting factors are on the exclusion side, and they're hard stops.
Prior authorization isn't explicitly called out in the NCD language, but don't let that fool you. The institutional approval process functions as a pre-condition for coverage. If your hospital hasn't gone through CMS's approval process and had it documented, you don't have a coverage policy that works in your favor — you have an unfunded transplant.
The coverage also sits under two Medicare benefit categories: Inpatient Hospital Services and Physicians' Services. That means your billing team needs clean coordination between the hospital's UB-04 and the physician's CMS-1500 for these cases. Any mismatch in diagnosis coding or facility status between those two claims creates unnecessary denial exposure.
CMS Pediatric Liver Transplantation Exclusions and Non-Covered Indications
Two patient-level exclusions in the NCD 71 coverage policy are absolute. CMS will not cover pediatric liver transplantation for:
| # | Excluded Procedure |
|---|---|
| 1 | Children with a malignancy extending beyond the margins of the liver |
| 2 | Children with persistent viremia |
These aren't soft exclusions. There's no prior authorization pathway around them, no appeals argument based on individual clinical circumstances. If your patient meets either criterion, Medicare will not reimburse the transplant.
The real issue here is documentation at the time of claim submission. Your billing team needs to confirm that the operative record and attending notes explicitly address both of these exclusion criteria — and rule them out — for every pediatric liver transplant billed to Medicare. A claim that doesn't document the absence of extrahepatic malignancy or viremia is a claim waiting to be denied on post-payment review.
This is also where your clinical documentation improvement (CDI) team needs to be looped in before the case closes. Don't let this become a retrospective fix.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Extrahepatic biliary atresia (patient under age 18) | Covered | No specific codes listed in NCD 71 | Must be performed at CMS-approved pediatric transplant facility |
| End-stage liver disease, other forms (patient under age 18) | Covered | No specific codes listed in NCD 71 | Must be performed at CMS-approved pediatric transplant facility |
| Malignancy extending beyond liver margins (any age) | Not Covered | No specific codes listed in NCD 71 | Hard exclusion — no exception pathway |
| Persistent viremia (any age) | Not Covered | No specific codes listed in NCD 71 | Hard exclusion — no exception pathway |
| Pediatric liver transplant at non-CMS-approved hospital | Not Covered | No specific codes listed in NCD 71 | Institutional approval required — see facility criteria below |
| Transplant at a pediatric hospital under joint program with CMS-approved facility | Covered (if criteria met) | No specific codes listed in NCD 71 | Joint program must share surgeons and quality assurance program |
CMS Pediatric Liver Transplantation Billing Guidelines and Action Items 2026
The institutional approval requirements in this coverage policy are where most billing teams have the most exposure. Here's what to act on now, before January 9, 2026.
| # | Action Item |
|---|---|
| 1 | Confirm your facility's CMS approval status. If your hospital performs pediatric liver transplants under a joint program with another CMS-approved facility, pull the original approval documentation now. Verify it still reflects your current program structure. If the program has changed — different surgeons, restructured oversight, new patient protocols — your approval may not cover current operations. |
| 2 | Audit your joint program documentation. The NCD requires that unified programs share the same transplant surgeons and the same quality assurance program. That means the same oversight committee, the same patient protocol, and the same patient selection criteria. If your hospital and the partnering facility have diverged on any of these, talk to your compliance officer before the effective date of January 9, 2026. |
| 3 | Review your pre-claim checklist for the two hard exclusions. For every pediatric liver transplant billed to Medicare, confirm the attending physician has documented the absence of malignancy beyond liver margins and the absence of persistent viremia. Build this into your charge capture workflow, not your denial management workflow. |
| 4 | Coordinate UB-04 and CMS-1500 diagnosis coding. Both Inpatient Hospital Services and Physicians' Services are listed as benefit categories. Your hospital billing team and the transplant surgeon's billing team need to align on diagnosis codes before either claim drops. A mismatch is a red flag on post-payment audit. |
| 5 | Check whether your MAC has issued a Local Coverage Determination (LCD) that supplements NCD 71. NCDs set the national floor, but your Medicare Administrative Contractor may have added regional criteria or documentation requirements. Contact your MAC or check their website for any pediatric liver transplantation LCDs active as of January 2026. |
| 6 | If you're billing for a pediatric hospital operating under a joint program, document that the joint program meets the April 12, 1991 Federal Register institutional criteria. That specific reference is in the NCD language. If your team can't locate documentation tying your program to those criteria, this is a compliance conversation — loop in your compliance officer and legal counsel before billing any new cases under this policy. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Pediatric Liver Transplantation Under NCD 71
The NCD 71 policy document does not list specific CPT, HCPCS, or ICD-10 codes. This is worth flagging directly: the absence of code-level guidance in the NCD itself means your coding team carries more responsibility for selecting the right procedure and diagnosis codes from standard code sets.
For pediatric liver transplantation billing, your coding team should reference the American Medical Association's CPT codebook for transplant surgery codes and consult ICD-10-CM for diagnosis codes corresponding to extrahepatic biliary atresia and end-stage liver disease by etiology. Your MAC's claims processing instructions — referenced in the NCD but not reproduced here — may include code-specific guidance.
Do not assume that because NCD 71 doesn't list codes, your MAC's system won't flag mismatches. Build your internal mapping from your coders' research and MAC guidance, then document it. That internal crosswalk is your defense on audit.
What the Joint Program Requirement Actually Means for Pediatric Liver Transplantation Billing
This section matters most to billing teams at children's hospitals that don't perform transplants independently. The NCD creates a specific pathway for pediatric hospitals to bill for liver transplants under a joint arrangement with a CMS-approved adult transplant program.
The three conditions are specific. The hospital's program must be operated jointly with a CMS-approved facility. The joint program must share transplant surgeons — not just credentialing, but actual shared surgeons. And it must share the quality assurance infrastructure: the same oversight committee, the same patient protocol, and the same selection criteria.
If any of those three conditions isn't met, the pediatric hospital's claims don't have a coverage basis under this NCD. That's not a gray area. That's a full denial.
The reference to the April 12, 1991 Federal Register notice is specific and dated. That document sets the institutional criteria the partnering CMS-approved facility must meet. If your compliance team hasn't pulled that notice and confirmed your program partner still meets those criteria under current operations, that's a gap worth closing before January 9, 2026.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.